These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6148436)

  • 1. [Dopamine antagonists and their mechanism of action].
    Yamada K; Furukawa T
    Nihon Rinsho; 1984 Apr; 42(4):808-14. PubMed ID: 6148436
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
    Imazu Y; Kobayashi K; Shomori T
    Seishin Shinkeigaku Zasshi; 1988; 90(10):845-52. PubMed ID: 3251268
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics.
    Costa E
    Adv Biochem Psychopharmacol; 1977; 16():557-63. PubMed ID: 18900
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioural data suggesting the plurality of central dopamine receptors.
    Costentin J; Dubuc I; Protais P
    Adv Biochem Psychopharmacol; 1983; 37():289-97. PubMed ID: 6138951
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of selective dopamine D-1 and D-2 antagonists on the locomotor response and brain monoamine changes induced by naloxone-precipitated morphine withdrawal in guinea pigs.
    Brent PJ; Chahl LA
    Prog Clin Biol Res; 1990; 328():515-8. PubMed ID: 2406762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of dopamine receptors and psychopharmacotherapy in children.
    Guérin P; Barthélémy C; Garreau B; Héraut J; Muh JP; Lelord G
    Acta Paedopsychiatr; 1993; 56(2):139-51. PubMed ID: 7510920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
    Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 12. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics.
    Scatton B; Dedek J; Korf J
    Adv Biochem Psychopharmacol; 1978; 19():373-5. PubMed ID: 29452
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B
    J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
    Jenner P; Marsden CD
    Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
    [No Abstract]   [Full Text] [Related]  

  • 20. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.